Nuo Therapeutics Inc (OTCQX US:NUOT)

Data as of Jan 30
 -0.0009 / -0.29%
Today’s Change
Today|||52-Week Range
Institutional investors purchased a net $14.9 thousand shares of NUOT during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 6.84% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Other institutional6.82%
Individual stakeholders10.39%
Mutual fund holders0.01%

Largest Quarterly Institutional

Chart unavailable

Latest Institutional Activity

Top 10 Owners of Nuo Therapeutics Inc

Total value ($)Shares
bought / sold
Frigate Ventures LP6.79%8,452,7252,958,454+8,452,725--
Edge Wealth Management LLC0.02%27,0009,45000.00%
Manulife Asset Management Ltd.0.01%17,0845,979+14,864+669.55%
Joel Isaacson & Co. LLC0.01%10,0003,50000.00%
Deerfield Management Co. LP0.00%000--

Top 10 Mutual Funds Holding Nuo Therapeutics Inc

Mutual fundStakeShares
Total value ($)Shares
bought / sold
John Hancock VIT - Total Stock Ma...0.01%17,0845,979+14,864+669.55%

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.